Here's the live share price of Supriya Lifescience along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Supriya Lifescience has gained 14.10% CAGR. Over the past year, the corresponding return has been 6.51%.
Supriya Lifescience’s current P/E of 33.32x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Supriya Lifescience | 2.39 | 1.23 | 2.68 | 10.74 | 6.51 | 48.69 | 14.10 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Supriya Lifescience has gained 6.51% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Supriya Lifescience has outperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 736.99 | 743.35 |
| 10 | 737.15 | 741.18 |
| 20 | 742.82 | 743.51 |
| 50 | 750.87 | 741.5 |
| 100 | 715.34 | 727.9 |
| 200 | 703.57 | 700.59 |
In the latest quarter, Supriya Lifescience remained same as its previous close in promoter holding, while DII stake increased to 5.22%, FII holding fell to 5.46%, and public shareholding moved up to 21.02% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 91,519 | 1.55 | 6.84 | |
| 25,370 | 0.82 | 1.9 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 26, 2025, 10:54 PM IST | Supriya Lifescience - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 18, 2025, 4:18 PM IST | Supriya Lifescience - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 13, 2025, 10:50 PM IST | Supriya Lifescience - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 13, 2025, 8:12 PM IST | Supriya Lifescience - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 12, 2025, 11:32 PM IST | Supriya Lifescience - Announcement under Regulation 30 (LODR)-Investor Presentation |
Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 696.49 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Supriya Lifescience is ₹755.00 as on Dec 24, 2025.
The Supriya Lifescience is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Supriya Lifescience is ₹6,076.45 Cr as on Dec 24, 2025.
Today’s highest and lowest price of Supriya Lifescience are ₹763.70 and ₹751.00.
The 52-week high/low is the highest and lowest price at which Supriya Lifescience stock has traded in the past 52-week or nearly a year. The 52-week high of Supriya Lifescience is ₹841.70 and 52-week low of Supriya Lifescience is ₹556.85 as on Dec 24, 2025.
The Supriya Lifescience has shown returns of 0.52% over the past day, 1.23% for the past month, 2.68% over 3 months, 6.51% over 1 year, 48.69% across 3 years, and 14.1% over 5 years.
P/E ratio of and PB ratio of Supriya Lifescience are 33.32 and 5.62 on Dec 24, 2025. While the company gives a dividend yield of 0.00 per annum.